新兴的魔法子弹:针对细胞下器官的向癌症治疗
Yue Yan1, Yimeng Zhang2,3, Jianxiong Liu2,3
1Department of Central Laboratory, Peking University First Hospital, Beijing, China.
Medical review (2021)
|April 14, 2025
概括
针对特定的亚细胞器官提供了一个精确的方法来治疗癌症,提高药物的疗效和减少副作用. 这一策略增强了抗癌药物供应和保留,以获得更好的治疗结果.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 细胞生物学 细胞生物学
背景情况:
- 抗癌药物的有效性取决于度和留在目标部位.
- 仅仅增加药物度不足以有效治疗癌症,尤其是细胞内点.
- 扩散的限制和非特异性相互作用需要先进的药物输送策略.
研究的目的:
- 审查细胞下器官向癌症治疗策略.
- 总结药物向分发和用于器官向的输送方法.
- 突出亚细胞向的意义和临床翻译考虑.
主要方法:
- 关于细胞下器官向癌症治疗的综合文献综述.
- 对细胞内药物向分布的分析.
- 对特定有机体的各种有针对性的交付策略的评估.
主要成果:
- 以亚细胞器官为向的癌症疗法在根除癌细胞方面提供了非常精确的精度.
- 这种方法提供了优势,如尽量减少剂量,减少副作用,优化疗效,并扭转多药物耐药性.
- 由于这些向治疗的潜力,引起了大量的研究兴趣.
结论:
- 向亚细胞器官是改善癌症治疗的有希望的策略.
- 有效的临床翻译需要仔细考虑向策略和药物分销.
- 在这个领域进行进一步的研究有可能在瘤学方面取得重大进展.
更多相关视频
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
11.0K
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
1.7K
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Tumor Immunotherapy
404
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
404
Cancer Stem Cells and Tumor Maintenance
4.6K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.6K
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
